Articles by: Geisel Communications

Sometimes Data Can Get You Only So Far

VT Digger – In this opinion piece, Paul Manganiello, emeritus professor of obstetrics and gynecology and current student at the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, discusses his internship experience working with a gun safety advocacy group in Vermont.

MTV generation faces a rude retirement wake-up call

MSN Money (via Main Street) – References the recent study on the state of Social Security by Samir Soneji, assistant professor of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, and Harvard researchers, which forecasts that Social Security funds will be depleted by 2033. The article states that Generation X, whose ages range from 35 – 50 years old, may not benefit from the program.

Sell a disease to sell a drug

Washington Post – An opinion piece by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on how the Food and Drug Administration is pushing back against the over-prescribing of testosterone.

Graceful Health: Bad bugs of summer

Brattleboro Reformer – An article by Kenneth Rudd, assistant professor of community and family medicine, on insects that spread diseases in the northeast and facts associated with how the diseases are transmitted. “Some bugs are fascinating and beautiful, some are simply a nuisance. Of more concern, though, are bugs that spread disease. While it’s important not to overreact or hide indoors, it’s equally important to have reliable facts,” says Rudd

Your Next Prescription Could Be a Genome Sequence

Huffington Post via Techonomy – Quotes Gregory Tsongalis, professor of pathology, on the use of genome sequencing to improve patient care. Looking ahead, Tsongalis sees every indication that genome sequencing will become a mainstay in hospitals, and he thinks advances in the field will keep pouring in.

Drug Derived From Scorpion Venom Will Target Brain Cancer in Kids

Seattle Times – Quotes David Roberts, professor of surgery and neurology, on news that Seattle Children’s Hospital will be testing a new dye derived from scorpion venom that lights up cancer cells so surgeons can see — and remove — deadly brain tumors. Roberts and other colleagues have also been testing a similar drug compound, 5-aminolevulinic acid (5-ALA), which targets glial tumors.

Are Your Patients Monitoring You?

Health IT Outcomes – Quotes Glyn Elwyn, professor of community and family medicine and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on the recent trend of patients recording interactions with their physicians during visits to the doctors office.

Appetizing Edibles for Colonoscopy Bowel Prep in Development

Medscape – Quotes L. Campbell Levy, assistant professor of medicine, on alternative menu items that may soon replace the typical purgatives used to prepare the bowel for a colonoscopy. An edible preparation that “incorporates the purgatives into an appealing diet for patients” is challenging the notion that you have to fast and consume the commonly despised liquid before a colonoscopy, Levy explains.